Pharmacogenomics in action: learning from the UK, looking towards Malaysia

Pharmacogenomic implementation, utilizing the United Kingdom's (UK) established operational framework to inform strategic directions for Malaysia. The research evaluates how incorporating genetic profile data into routine prescribing practices optimizes pharmacological therapy, mitigates adverse drug reactions (ADRs), and enhances personalized patient care. The findings demonstrate that the UK's experience in embedding genomic testing into national healthcare delivery provides valuable policy, data infrastructure, and workforce training models essential for establishing a sustainable precision medicine ecosystem in Malaysia. The implications of this study underscore the critical need for collaborative policy frameworks among healthcare administrators, clinical practitioners, and pharmaceutical researchers to facilitate the seamless integration of pharmacogenomics into local health systems.